Agilent Technologies Inc.
Agilent Technologies Reports Q1 FY2026 Results, Raises Full-Year Guidance
Summary
Agilent Technologies, Inc. reported solid financial results for the first quarter of fiscal year 2026, with revenue of $1.80 billion, a 7.0% increase from the first quarter of 2025. The company reported GAAP net income of $305 million, or $1.07 per share, and non-GAAP net income of $386 million, or $1.36 per share, up 4% from the prior year quarter. The company also raised its full-year revenue outlook and increased its non-GAAP EPS guidance, while confirming core revenue growth and margin expansion for the full year.
Get alerts for A
Be first to know when Agilent Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About Agilent Technologies Inc.
Agilent Technologies Inc. is a global leader in the development and provision of life sciences, diagnostics, and applied chemical markets. Primarily focused on delivering superior analytical instruments, software, services, consumables, and reagents, the company plays a critical role in supporting the research needs of pharmaceutical, biotechnology, and government laboratories. Agilent's robust portfolio includes innovative solutions for genomics, proteomics, and metabolomics, aiding in critical areas such as disease research, food safety, and environmental analysis. Established in 1999 as a spin-off from Hewlett-Packard, the company leverages its heritage of technological innovation to enhance analytical capabilities for its clients. Agilent's significant contributions to health and safety applications underscore its importance in advancing scientific understanding and supporting public health initiatives worldwide.
Official SEC Documents
Advertisement